Deal Announcements

Cerecor Garners Series A Venture Capital Funding

Tuesday, September 17, 2013 5:31:00 AM PDT | VentureDeal

   Baltimore, Maryland  --  Biopharmaceutical company Cerecor has secured $6.8 million in its Series A-1 round of institutional venture capital financing.

Cerecor is developing "prescription pharmaceuticals whose primary activities in the human brain."

Investors in the financing were not disclosed.

The company said it would use the financing to complete the acquisition and technology transfer of a candidate for the treatment of depression.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1